# EDGAR Filing Document

**Accession Number:** 0000101538
**File Stem:** 0001104659-26-061217
**Filing Date:** 2026-5
**Character Count:** 38857
**Document Hash:** ff5e3d073c8fd433abcb8d0e8330ac5b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-061217.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001104659-26-061217

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260514

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260514

**DATE AS OF CHANGE**: 20260514

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNITED STATES ANTIMONY CORP
- **CENTRAL INDEX KEY:** 0000101538
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRIMARY SMELTING & REFINING OF NONFERROUS METALS [3330]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 810305822
- **STATE OF INCORPORATION:** MT
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08675
- **FILM NUMBER:** 26979423

**BUSINESS ADDRESS:**
- **STREET 1:** 4438 W LOVERS LANE
- **STREET 2:** UNIT 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75209
- **BUSINESS PHONE:** 4068273523

**MAIL ADDRESS:**
- **STREET 1:** 4438 W LOVERS LANE
- **STREET 2:** UNIT 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75209

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AGAU MINES INC
- **DATE OF NAME CHANGE:** 19740728

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported) **<u>May 14, 2026</u>**

---

| |
|:---|
| **UNITED STATES ANTIMONY CORPORATION** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Texas** | **001-08675** | **81-0305822** |
| (State or other jurisdiction<br> of incorporation)  | (Commission<br> File No.) | (IRS Employer<br> Identification Number) |

---

---

| | |
|:---|:---|
| **4438 W. Lovers Lane** **, Unit 100, Dallas, TX** | **75209** |
| (Address of principal executive officers) | (Zip Code) |

---

Registrant's telephone number, including area code: **(406) 606-4117**

**<u>Not Applicable</u>**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

---

| |
|:---|
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |

---

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value | UAMY | NYSE |
| Common Stock, $0.01 par value | UAMY | NYSE Texas |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 2.02 Results of Operations and Financial Condition.**

On May 14, 2026, United States Antimony Corporation ("USAC", "US Antimony", or the "Company") issued a press release reporting its financial results for first quarter 2026. This press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The foregoing disclosure is qualified in its entirety by the full text of the Press Release.

The information in this Item 2.02, including Exhibit 99.1 attached hereto, of this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.

**Cautionary Note Regarding Forward-Looking Statements**

This Current Report on Form 8-K, including the Press Release furnished as Exhibit 99.1 to this Current Report on Form 8-K, contains forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, judgment, and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct, and you should be aware that actual events or results may differ materially from those contained in the forward- looking statements. Words such as "will," "expect," "intend," "plan," "potential," "possible," "goals," "accelerate," "continue," and similar expressions identify forward-looking statements.

Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, those described in the Company's filings on Form 10-K, Form 10-Q, and Form 8-K with the United States Securities and Exchange Commission.

All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You should not rely upon any forward-looking statements as predictions of future events. The Company undertakes no obligation to revise or update any forward-looking statements made in this Current Report on Form 8-K to reflect events or circumstances after the date hereof, to reflect new information or the occurrence of unanticipated events, to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, in each case, except as required by law.

**Item 9.01 Financial Statements and Exhibits.**

(d) *<u>Exhibits.</u>*

---

| | |
|:---|:---|
| Exhibit No. | Description |
| [**99.1**](tm2614673d1_ex99-1.htm) | [**Press Release issued by United States Antimony Corporation dated May 14, 2026**](tm2614673d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded with the inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **UNITED STATES ANTIMONY CORPORATION** | **UNITED STATES ANTIMONY CORPORATION** |
| Dated: | May 14, 2026 | By: | /s/ Shawn P. Winkler |
|  |  | Shawn P. Winkler | Shawn P. Winkler |
|  |  | Interim Chief Financial Officer | Interim Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](tm2614673d1_ex99-1img001.jpg)

**United States Antimony Corporation Reports**

**First Quarter 2026 Financial and Operating Results**

***Received $12.8 Million in Department of War ("DoW") Grant Milestones for Thompson Falls Expansion***

***First Two Delivery Notices under the $245 MM Defense Logistics Agency ("DLA") Contract Completed***

***Q1 2026 Revenues of $6.8 Million; Net Loss of $11.3 Million, or $(0.08) per Diluted Share***

***Post-Quarter Equity Issuances Generated $48.6 Million in Gross Proceeds***

***Reiterates Full-Year 2026 Gross Revenue Guidance of $125 Million***

***"The Critical Minerals and ZEO Company"***

***~ Antimony, Cobalt, Gold, Tungsten, and Zeolite ~***

**DALLAS, TX / ACCESS Newswire / May 14, 2026** / United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company") (NYSE: UAMY) (NYSE Texas: UAMY), a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia, today reported its financial and operating results for the first quarter ended March 31, 2026.

**First Quarter 2026 Highlights**

· Revenues
 of $6.8 million, compared to $7.0 million in Q1 2025

· Gross
 profit of $1.1 million (16% gross margin), compared to $2.4 million (34% gross margin) in
 Q1 2025

· Operating
 loss of $7.5 million, compared to operating income of $0.4 million in Q1 2025

· Net
 loss of $11.3 million, including $9.3 million of net non-cash items, compared to net income
 of $0.6 million in Q1 2025

· Achieved
 $12.8 million (out of $27 Million) in Department of War ("DoW") grant milestones
 at the Thompson Falls expansion project, recognized as a grant receivable with a corresponding
 reduction to construction in progress (PP&E)

· Acquired
 the Radersburg flotation mill in Montana for $4.8 million, further advancing the Company's
 vertical integration strategy

· Cash
 and cash equivalents, including held-to-maturity U.S. Treasury securities of $23.7 million
 at quarter-end; Subsequent to quarter-end, the Company raised approximately $48.6 million
 of gross proceeds through the issuance of approximately 4.2 million shares of common stock
 at an average price of $11.57 per share. Total liquidity, pro forma for the post March 31,
 2026 stock issuances is $108.7 million, including cash, U.S. Treasury securities and our
 Larvotto Resources Limited (ASX: LRV) marketable securities discussed subsequently in this
 release.

· Reiterating
 full-year 2026 gross revenue guidance of $125 million

**Strategic Overview**

During the first quarter of 2026, the Company continued to advance its strategy to build a fully integrated critical minerals platform supporting U.S. national security and supply chain resiliency. Key accomplishments during the quarter included the achievement of milestones under the Company's DoW grant program, the acquisition of the Radersburg flotation mill, first delivery notice to the DLA under the $245 Million Contract, the formation of a new hydrometallurgical joint venture with Americas Gold and Silver, and continued progress on the Thompson Falls smelter expansion, which is nearing completion and is expected to come online over the next few weeks. The company also provided a Technical Report Summary of its Fostung Tungsten project in April 2026 reflecting future potential revenues of $4.6 Billion over the life of the property, based on the assumptions detailed in the report.

**First Quarter 2026 Financial Results**

Revenues for the first quarter of 2026 were $6.8 million, compared to $7.0 million in the first quarter of 2025. Antimony segment revenues were $5.6 million, compared to $5.9 million in the prior year period, with antimony pounds sold decreasing approximately 23% to 278,797 pounds from 362,647 pounds. The volume decline reflects timing of customer orders and shipments primarily, none of which were to the government. Average sales price per pound of antimony rose approximately 22% to $19.92 from $16.34.

Cost of revenues increased to $5.67 million from $4.63 million, and gross profit decreased to $1.11 million from $2.37 million in Q1 2025. Gross margin of approximately 16% (down from 34% in the prior year period) primarily reflects higher antimony cost per pound sold, which rose approximately 69% to $16.28 from $9.66 as higher-cost ore moved through cost of sales. Q1 2026 gross margin did not benefit from any of the processing of the Company's in-house antimony mined in Montana or from any antimony deliveries under the Company's contract with the DLA. Both of these events are expected to begin contributing during the remaining quarters of 2026 as both Montana-based mining is processed and the Thompson Falls expansion comes online.

Zeolite revenue was $1.0 million in Q1 2026 compared to $1.1 million in Q1 2025, driven by a 3% decrease in sales volume (tons sold of 3,681 versus 3,802) and 4% decrease in average sales price per ton. These sales have dramatically improved over the last sixty (60) days due to obtaining new customer relationships with the Company's expanded sales efforts.

The Company's current antimony inventory is a combination sourced from international third-party suppliers as well as mined from the Company's owned Stibnite Hill, Montana mining claims. The value of our antimony inventory is approximately $21.7 million on March 31, 2026 compared to $12.0 million as of December 31, 2025 and $3.6 million as of March 31, 2025, a 80.8% increase and 502.8% increase, respectively.

Operating expenses were $8.6 million in the first quarter of 2026, compared to $2.0 million in the prior year period. The increase of $6.6 million reflects increased expense associated with the build-out of the Company's leadership team, which continues, and operational infrastructure necessary to execute the Company's vertical integration strategy. Operating expenses included approximately $4.8 million of non-cash share-based compensation expense (compared to $0.25 million in Q1 2025), reflecting expanded equity grants tied to leadership hiring and share price appreciation experienced during the period.

The Company recorded an operating loss of $7.5 million in the first quarter of 2026, compared to operating income of $0.4 million in the prior year period. Net loss attributable to the Company was $11.3 million, or ($0.08) per diluted share, compared to net income of $0.6 million, or nil per diluted share, in the prior year period. The Q1 2026 net loss includes approximately $9.3 million of net non-cash items, comprised principally of $4.8 million of share-based compensation expense, $4.1 million of unrealized loss on the Company's investment in marketable equity securities (Larvotto Resources Limited), and $0.4 million of depreciation and amortization.

**Liquidity, Capital Resources, and Subsequent Events**

At March 31, 2026, the Company had cash and cash equivalents and investments in held-to-maturity U.S. Treasury securities totaling liquid resources of $23.7 million. This compares to $30.5 million of cash and cash equivalents and $20.4 million of held-to-maturity Treasury securities at December 31, 2025. The decrease in cash during the quarter reflects $12.1 million used in operating activities (primarily working-capital investment made in antimony feedstock inventory), $12.6 million used in investing activities (discussed subsequently), and $2.6 million used in financing activities (principally treasury share repurchases related to employee equity award settlements). The Company also retains a $19.0 million margin credit facility with a bank, which was undrawn at March 31, 2026.

Subsequent to March 31, 2026 and through the date of this release, the Company sold approximately 4.2 million shares of common stock at an average price of approximately $11.57 per share, generating gross proceeds of approximately $48.6 million. These proceeds substantially offset the cash used during the first quarter to fund inventory build, the Radersburg mill acquisition, and the portion of the Thompson Falls construction in progress not yet reimbursed from the DoW.

In addition, the Company holds an investment in publicly traded equity securities (Larvotto Resources Limited (with a quarter-end fair value of USD $36.4 million, and a current market value as of close on May 13, 2026 of USD $46.6 million, an increase of USD $10.1 million since March 31, 2026.

**Capital Expenditures and Department of Defense Grant**

Capital expenditures during the first quarter of 2026 totaled $12.6 million, including $4.8 million for the acquisition of the Radersburg flotation mill in Montana, approximately $4.6 million for the construction-in-progress expansion of the Thompson Falls antimony smelter, and approximately $3.2 million primarily for new mineral rights acquisitions of other critical minerals.

During the first quarter, the Company achieved milestones under its Defense Production Act grant award from the DoW, resulting in formal approval by the Defense Industrial Base Consortium for the completion of three project milestones representing $12.8 million of obligated funding. In accordance with the Company's early adoption of ASU 2025-10, Government Grants (Topic 832), effective January 1, 2026, the Company recognized the $12.8 million as a government grant receivable on the balance sheet, with a corresponding reduction to the carrying amount of construction in progress associated with the Thompson Falls expansion. According to accounting standards, the grant funding does not flow through revenue or net income; rather, it reduces the cost basis of the related long-lived assets, lowering future depreciation expense. The total DoW grant award is $27.0 million, of which $16.2 million has been obligated to date; the remaining award amount of $10.8 million is subject to future authorization.

**Operating and Strategic Updates**

During and subsequent to the first quarter, the Company made progress across its critical minerals platform:

· Thompson
 Falls Expansion: The Company's smelter expansion at Thompson Falls, Montana is nearing completion
 and is expected to come online over the next few weeks, significantly increasing domestic
 antimony processing capacity, not only for the Company, but for the country.

· Radersburg
 Flotation Mill: The Company acquired the Radersburg flotation and concentration facility
 in Montana for $4.8 million, supporting vertical integration of the Company's antimony processing
 operations. A new critical minerals testing laboratory has recently been installed. Now that
 this asset is 100% owned, no prior lease payments incurred for a similar facility will be
 incurred.

· Hydrometallurgical
 Joint Venture: The Company entered into a joint venture agreement with Americas Gold and
 Silver Corporation ("Americas") as announced on February 10, 2026 (see press
 release of same date) to construct and operate a new, state-of-the-art hydrometallurgical
 processing facility. The joint venture will be owned 51% by Americas and 49% by the Company,
 with the Company serving as managing member. Under the terms of the agreement, Americas will
 contribute the project site and existing infrastructure, along with feedstock, while the
 Company will contribute its proprietary North America hydrometallurgical processing technology
 and technical expertise. Capital contributions for the facility's construction are
 expected to be funded pro-rata based on ownership interests, unless otherwise agreed. Primary
 site-level environmental and operating permits have been obtained, while certain construction
 permits are pending. An application for funding the cost of construction of the project has
 been made to the DoW.

· DLA
 Contract: The Company has received approximately $12 million in sales orders under its existing
 contract with the U.S. DLA. No revenue under this contract was recognized during Q1 2026.
 Additionally, the first and second delivery notices of finished product (antimony ingots)
 have been given to the DoW.

· On
 April 10, 2026 (see announcement of same date), the Company provided an operational
 update on its 100% owned Fostung Project, an intermediate-stage tungsten exploration asset
 located in Sudbury District, Ontario by making available its Technical Report Summary ("TRS")
 on the property, which disclosed Inferred Mineral Resources of approximately 14.7 million
 tons at 0.17% WO₃, containing approximately 54 million pounds of tungsten trioxide
 and future resource revenue potential of up to $4.6 Billion over the life of the property
 based on the assumptions in the TRS.

**2026 Outlook**

The Company is reiterating its full-year 2026 gross revenue guidance of approximately $125 million. Achievement of this guidance is dependent on, among other factors, the timing of antimony shipments under the DoW contract, the timely commissioning of the Thompson Falls expansion during the second quarter, ramp-up of in-house antimony ore processing in both Mexico and Montana, and continued strength in critical minerals demand. The majority of full-year 2026 revenue is expected to be weighted towards the second half of the year. There can be no assurance that these factors will develop as currently anticipated; see the "Forward-Looking Statements" section below.

**Management Commentary**

Commenting on the first quarter 2026 results, Mr. Gary C. Evans, Chairman and Chief Executive Officer of US Antimony Corporation, stated: "When you are building a vertical business at the speed we are achieving at USAC, things rarely move in a straight line. There will be bumps in the road. Our first quarter results reflect a deliberate investment phase for our future. I told the 'street' during our year-end conference call that our total operating results were likely to be 'bumpy' this year. The increase in operating expense, the inventory build, and the capital expenditures we made in the quarter are the necessary foundation for the production scale-up we expect during the balance of 2026. While these investments drove a near-term loss, primarily all non-cash related, we believe we are much better positioned for the Company to deliver materially stronger financial performance in future reporting periods as our Montana-based mining, processing, and expanded smelting capabilities come online and integrate with our own material over the course of the year."

Mr. Evans continued: "We are particularly pleased with the progress under our DoW grant program, the addition of the Radersburg flotation mill, and the formation of our hydrometallurgical joint venture, each of which advances the vertical integration of our critical minerals platform. While government grant requests are never guaranteed, we believe our three official filings made since the first of this year, which total $274 million, are 'on point' and meet the standards established by these various governmental agencies in their desire to expedite 'home grown' critical mineral development, both in the field as well as our proprietary downstream refining processes. The positive feedback we have received to date gives us encouragement of our continued success in this endeavor. Combined with our existing DLA contract, where we have noticed the government for two deliveries, our existing pipeline of additional governmental grant requests, and the post-quarter strengthening of our balance sheet, we are well-positioned to continue executing our 2026 business plan. The additional equity capital we have raised since the end of March is to guarantee we are in a position of strength to achieve these lofty goals and objectives."

**Conference Call Details**

US Antimony management will host a conference call on Thursday, May 14, 2026 at 4:15 p.m. Eastern time to discuss its first quarter 2026 financial and operating results, followed by a question-and-answer period.

**Date:** Thursday, May 14, 2026

**Time:** 4:15 p.m. Eastern time

**Toll-free dial-in:** 888-506-0062

**International dial-in:** 973-528-0011

**Participant access code:** 130357

**Webcast URL:** <u>https://www.webcaster5.com/Webcast/Page/2604/53986</u>

A replay of the conference call and the transcript will be available in the Investors section of the Company's website at <u>https://www.usantimony.com/investors</u>.

**About United States Antimony Corporation**

United States Antimony Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," "U.S. Antimony," the "Company," "Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S., Mexico, and Canada. The Company mines, purchases, and processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The Company also recovers precious metals, primarily gold and silver, at its Montana facility from third-party ore. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. From 2024 through 2026, the Company has acquired mining claims, real properties (patented claims), and leases located in Alaska, Montana, and Ontario, Canada — including the Radersburg flotation mill acquired in the first quarter of 2026 — to reduce the cost of third-party antimony ore purchases and to expand its product offerings.

Learn more about United States Antimony Corporation at <u>www.usantimony.com</u>.

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company's full-year 2026 revenue guidance, the expected commissioning of the Thompson Falls smelter expansion, the expected development and contribution of the Fostung Tungsten project, the expected timing and contribution of shipments under the DLA contract, the expected impact of in-house ore processing on margins, the recognition and continuation of funding under the DoW grant program, the expected use of post-quarter equity issuance proceeds, the application of new accounting pronouncements (including ASU 2025-10), and other statements that are not historical facts. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as management's beliefs and assumptions. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," "could," and variations of these words or similar expressions are intended to identify such forward-looking statements.

Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in such statements, including, but not limited to: fluctuations in the market prices and demand for antimony and zeolite; changes in domestic and global economic conditions; operational risks inherent in mining and mineral processing; geological or metallurgical conditions; availability and cost of energy, equipment, transportation, and labor; the Company's ability to maintain or obtain permits, licenses, and regulatory approvals; changes in environmental and mining laws or regulations; competitive factors; the impact of geopolitical developments; and the effects of weather, natural disasters, or health pandemics on operations and supply chains. Additional information regarding risk factors that could cause actual results to differ materially is included in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

**Contacts**

---

| | |
|:---|:---|
| **Investor Relations Contact:**<br> Jonathan Miller, VP, Investor Relations<br> United States Antimony Corporation<br> 4438 W. Lovers Lane, Unit 100<br> Dallas, Texas 75209<br> Email: <u>Jmiller@usantimony.com</u><br> Phone: 406-606-4117 | &nbsp;&nbsp;**Media Relations Contact:**<br> Anthony D. Andora<br> Edge Consulting, Inc.<br> 1560 Market Street, Suite 701<br> Denver, Colorado 80202<br> Email: <u>Anthony@EdgeConsultingSolutions.com</u><br> Phone: 720-317-8927 |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Revenues | $6784069 | $7000005 |
| Cost of revenues | 5674602 | 4628275 |
| Gross profit | 1109467 | 2371730 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 1331969 | 550595 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salaries and benefits | 5879794 | 1000555 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 1281131 | 382036 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale or disposal of property, plant and equipment, net | (1900) | (500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 135668 | 81052 |
| Total operating expenses | 8626662 | 2013738 |
| Income (loss) from operations | (7517195) | 357992 |
| Other income (expense), net: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and investment income | 328288 | 192156 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on investment in equity securities | (4061430) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other miscellaneous expense, net | (28027) | (3624) |
| Total other income (expense), net | (3761169) | 188532 |
| Income (loss) before income taxes and equity in loss of joint venture | (11278364) | 546524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | - | - |
| Income (loss) before equity in losses of joint venture | (11278364) | 546524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in losses of joint venture | (16126) | - |
| Net income (loss) | (11294490) | 546524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred dividends | (1875) | (1875) |
| Net income (loss) available to common shareholders | 11296365) | $544649 |
| Net income (loss) per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 0.08) | $nil |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 0.08) | $nil |
| Weighted average shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 141612253 | 113703415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 141612253 | 122394861 |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES** 

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **March 31, <br> 2026** | **December 31,<br> 2025** |
| **ASSETS** | | |
| CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $3220400 | $30494320 |
| &nbsp;&nbsp;&nbsp;Investment in debt securities held to maturity | 4620170 | 4577706 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 2512957 | 4213305 |
| &nbsp;&nbsp;&nbsp;Government grant receivable | 12848246 |  |
| &nbsp;&nbsp;&nbsp;Inventories | 22026820 | 12522009 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 734552 | 434842 |
| &nbsp;&nbsp;&nbsp;Note receivable | 2445762 | 2500000 |
| Total current assets | 48408907 | 54742182 |
| Property, plant and equipment, net | 46668672 | 42374839 |
| Operating lease right-of-use assets | 38223 | 48106 |
| Investment in debt securities held to maturity - noncurrent | 15922926 | 15773251 |
| Investment in equity securities | 36432898 | 40494328 |
| Investment in joint venture | 83874 |  |
| Restricted cash for reclamation bonds | 163778 | 162756 |
| Other assets, net | 330207 | 330207 |
| Total assets | $148049485 | $153925669 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $9672375 | $6924518 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 3388210 | 2937842 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities - directors | 140958 | 143931 |
| &nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 27477 | 34103 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 138140 | 136942 |
| Total current liabilities | 13367160 | 10177336 |
| Operating lease liabilities, net of current portion | 10746 | 14003 |
| Long-term debt, net of current portion | 23495 | 58483 |
| Asset retirement obligations | 2753172 | 2720658 |
| Total liabilities | 16154573 | 12970480 |
| COMMITMENTS AND CONTINGENCIES (Note 5,9,15) |  |  |
| STOCKHOLDERS' EQUITY |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock $0.01 par value, 50,000,000 shares authorized: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A - no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series B - 750,000 shares issued and outstanding (liquidation preference $984,375 and $982,500, respectively) | 7500 | 7500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series C - 177,904 shares issued and outstanding (liquidation preference $97,847 both periods) | 1779 | 1779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series D - no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.01 par value, 250,000,000 shares authorized; 143,738,970 and 140,042,270 shares issued, respectively | 1437390 | 1400423 |
| &nbsp;&nbsp;&nbsp;Treasury stock (699,605 and 149,639 shares of common stock at cost, respectively) | (6372556) | (574153) |
| Additional paid-in capital | 193603838 | 185608189 |
| Accumulated deficit | (56783039) | (45488549) |
| Total stockholders' equity | 131894912 | 140955189 |
| Total liabilities and stockholders' equity | $148049485 | $153925669 |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net income (loss) | 11294490) | $546524 |
| Adjustments to reconcile income (loss) to net cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 410459 | 281970 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion of asset retirement obligation | 32514 | 19483 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncash operating lease expense |  | 146962 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 4833965 | 245384 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion income from investment securities held to maturity | (192139) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in-kind interest from notes receivable | (45762) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale or disposal of property, plant and equipment, net | (1900) | (500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in losses of joint venture | 16126 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Write-down of inventory to net realizable value | 161456 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in allowance for credit losses | 156 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on investment in equity securities | 4061430 |  |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 1700192 | (816722) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (9666267) | (2745387) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (299710) | (23428) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IVA receivable and other assets |  | (267993) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (2223094) | 1660372 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 450368 | (757919) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities – directors | (2973) | (18037) |
| Net cash used in operating activities | (12059669) | (1729291) |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment in joint venture | (100000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from notes receivable principal payment | 100000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of property, plant and equipment | 1900 | 500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (12581587) | (862511) |
| Net cash used in investing activities | (12579687) | (862011) |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal payments on long-term debt | (33790) | (32632) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercises of stock options | 48624 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock acquired | (4982634) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock, net of issuance costs | 1339446 | 2392317 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercise of warrants | 994812 | 806438 |
| Net cash (used in) provided by financing activities | (2633542) | 3166123 |
| **NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH** | (27272898) | 574821 |
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 30657076 | 18270898 |
| **CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD** | $3384178 | $18845719 |
| **SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest paid in cash | $1699 | $2937 |
| **NON-CASH FINANCING AND INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recognition of operating lease liability and right-of-use asset | $- | $63416 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment included in accounts payable | $4970951 | $- |

---